APOBEC3A and 3C decrease human papillomavirus 16 pseudovirion infectivity

Biochemical and Biophysical Research Communications

Volumn 457, Issue 3, 2015, Pages 295-299

  Monjurul, Ahasan Md ^a   Wakae, Kousho ^a   Wang, Zhe ^a,b   Kitamura, Kouichi ^a   Liu, Guangyan ^a   Koura, Miki ^a   Imayasu, Mieko ^a   Sakamoto, Naoya ^a   Hanaoka, Kousei ^a   Nakamura, Mitsuhiro ^a   Kyo, Satoru ^a,c   Kondo, Satoru ^a   Fujiwara, Hiroshi ^a   Yoshizaki, Tomokazu ^a   Mori, Seiichiro ^d   Kukimoto, Iwao ^d   Muramatsu, Masamichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b DALIAN UNIVERSITY   (China)

^c SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Antiviral activity; APOBEC3; HPV16; Pseudovirion

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3A; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3C; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3H; CAPSID PROTEIN; CAPSID PROTEIN L1; CAPSID PROTEIN L2; UNCLASSIFIED DRUG; APOBEC3A PROTEIN, HUMAN; APOBEC3C PROTEIN, HUMAN; CYTIDINE DEAMINASE; L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; PROTEIN; PROTEIN BINDING;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA SEQUENCE; EXPRESSION VECTOR; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOPRECIPITATION; INNATE IMMUNITY; MOLECULAR INTERACTION; PAPILLOMAVIRUS INFECTION; PLASMID; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PSEUDOVIRION; RNA EDITING; VIRION; VIRUS ASSEMBLY; VIRUS INFECTION; GENETICS; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; PATHOGENICITY; PHYSIOLOGY; VIRULENCE; VIRUS GENOME;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16; MIRIDAE;

CAPSID PROTEINS; CYTIDINE DEAMINASE; FEMALE; GENOME, VIRAL; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS, VIRAL; PROTEIN BINDING; PROTEINS; VIRION; VIRULENCE; VIRUS ASSEMBLY;

EID: 84922719882     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.12.103     Document Type: Article

References (23)

1. R. Goila-Gaur, K. Strebel, HIV-1 Vif, APOBEC, and intrinsic immunity, Retrovirology 5 (2008) 51.
2. R.S. Harris, M.T. Liddament, Retroviral restriction by APOBEC proteins, Nat. Rev. Immunol. 4 (2004) 868-877.
3. M.H. Malim, APOBEC proteins and intrinsic resistance to HIV-1 infection, Philos. Trans. R Soc. Lond. B Biol. Sci. 364 (2009) 675-687.
4. V.C. Vieira, M.A. Soares, The role of cytidine deaminases on innate immune responses against human viral infections, BioMed. Res. Int. 2013 (2013) 683095.
5. Y. Iwatani, D.S. Chan, F. Wang, K.S. Maynard, W. Sugiura, A.M. Gronenborn, I. Rouzina, M.C. Williams, K. Musier-Forsyth, J.G. Levin, Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G, Nucleic Acids Res. 35 (2007) 7096-7108.
6. D.H. Nguyen, S. Gummuluru, J. Hu, Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G, J. Virol. 81 (2007) 4465-4472.
7. K. Belanger, M. Savoie, M.C. Rosales Gerpe, J.F. Couture, M.A. Langlois, Binding of RNA by APOBEC3G controls deamination-independent restriction of retroviruses, Nucleic Acids Res. 41 (2013) 7438-7452.
8. J. Bodily, L.A. Laimins, Persistence of human papillomavirus infection: keys to malignant progression, Trends Microbiol. 19 (2011) 33-39.
9. H. Zur Hausen, Papillomaviruses and cancer: from basic studies to clinical application, Nat. Rev. Cancer 2 (2002) 342-350.
10. A.R. Kreimer, A.K. Chaturvedi, HPV-associated oropharyngeal cancers-are they preventable? Cancer Prev. Res (Phila) 4 (2011) 1346-1349.
11. M.A. Stanley, M.R. Pett, N. Coleman, HPV: from infection to cancer, Biochem. Soc. Trans. 35 (2007) 1456e1460.
12. Z. Wang, K. Wakae, K. Kitamura, S. Aoyama, G. Liu, M. Koura, A.M. Monjurul, I. Kukimoto, M. Muramatsu, APOBEC3 deaminases induce hypermutation in human papillomavirus 16 DNA upon Beta interferon Stimulation, J. Virol. 88 (2014) 1308-1317.
13. M.A. Stanley, H.M. Browne, M. Appleby, A.C. Minson, Properties of a non-tumorigenic human cervical keratinocyte cell line International journal of cancer, J. Int. du Cancer 43 (1989) 672-676.
14. D.V.P. Christopher, B. Buck, Douglas R. Lowy, John T. Schiller, Generation of HPV pseudovirions using transfection and their use in neutralization assays, in: J.D. Clare Davy (Ed.), Human Papillomavirus Methods and Protocols, Humana Press, London, 2006, pp. 445e462.
15. S. Mizushima, S. Nagata, pEF-BOS, a powerful mammalian expression vector, Nucleic Acids Res. 18 (1990) 5322.
16. S. Nakao, S. Mori, K. Kondo, K. Matsumoto, H. Yoshikawa, T. Kanda, Monoclonal antibodies recognizing cross-neutralization epitopes in human papillomavirus 16 minor capsid protein L2, Virology 434 (2012) 110-117.
17. K. Kitamura, Z. Wang, S. Chowdhury, M. Simadu, M. Koura, M. Muramatsu, Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA, PLoS Pathog. 9 (2013) e1003361.
18. C.B. Buck, D.V. Pastrana, D.R. Lowy, J.T. Schiller, Efficient intracellular assembly of papillomaviral vectors, J. Virol. 78 (2004) 751-757.
19. M.D. Stenglein, M.B. Burns, M. Li, J. Lengyel, R.S. Harris, APOBEC3 proteins mediate the clearance of foreign DNA from human cells, Nat. Struct. Mol. Biol. 17 (2010) 222-229.
20. Z. Surviladze, R.T. Sterk, S.A. DeHaro, M.A. Ozbun, Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy, J. Virol. 87 (2013) 2508-2517.
21. C.J. Warren, T. Xu, K. Guo, L.M. Griffin, J.A. Westrich, D. Lee, P.F. Lambert, M.L. Santiago, D. Pyeon, APOBEC3A functions as a restriction factor of human papillomavirus, J. Virol 89 (2015) 688-702.
22. L. Lackey, E.K. Law, W.L. Brown, R.S. Harris, Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination, Cell Cycle 12 (2013) 762e772.
23. K.F. Richards, M. Bienkowska-Haba, J. Dasgupta, X.S. Chen, M. Sapp, Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16, J. Virol. 87 (2013) 11426-11437.